Drugs that contain Minocycline Hydrochloride

1. List of Amzeeq drug patents

Can you believe AMZEEQ received compensation for the extended wait time during the regulatory approval process?
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10137200 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10086080 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10213512 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10517882 JOURNEY Method for healing of an infected acne lesion without scarring
Oct, 2030

(7 years from now)

US10821187 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(7 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US10849847 JOURNEY Compositions and methods for treating rosacea and acne
Sep, 2037

(14 years from now)

US10398641 JOURNEY Compositions and methods for treating rosacea and acne
Sep, 2037

(14 years from now)

Do you want to check out AMZEEQ patents from before 2022?

Market Authorisation Date: 18 October, 2019

Treatment: Treatment of non-nodular acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of AMZEEQ before it's patent expiration?
More Information on Dosage

AMZEEQ family patents

59

United States

6

Canada

IB

5

IB

2

Mexico

2

Australia

2

Israel

1

Brazil

1

China

1

South Africa

1

United Kingdom

1

European Union

2. List of Arestin drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6682348 ORAPHARMA Dispensing apparatus and cartridge
Mar, 2022

(1 year, 2 months ago)

US7699609 ORAPHARMA Dispensing apparatus and cartridge with deformable tip
Mar, 2022

(1 year, 2 months ago)

Do you want to check out ARESTIN patents from before 2022?

Market Authorisation Date: 16 February, 2001

Treatment: NA

Dosage: POWDER, EXTENDED RELEASE;DENTAL

More Information on Dosage

ARESTIN family patents

3

United States

2

Australia

2

European Union

1

Canada

1

Colombia

1

Cyprus

1

Argentina

1

Slovenia

1

Brazil

1

Denmark

1

Portugal

1

Spain

1

Japan

3. List of Minocin drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9278105 REMPEX Tetracycline compositions
May, 2031

(7 years from now)

US9084802 REMPEX Tetracycline compositions
May, 2031

(7 years from now)

Do you want to check out MINOCIN patents from before 2022?

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

How can I launch a generic of MINOCIN before it's patent expiration?
More Information on Dosage

MINOCIN family patents

8

United States

2

New Zealand

2

Spain

2

Japan

2

European Union

1

Colombia

1

Australia

1

Israel

1

Korea, Republic of

1

Canada

1

Denmark

1

Chile

1

Singapore

1

Portugal

1

Russia

1

Poland

1

Hong Kong

1

Mexico

1

Brazil

1

China

1

South Africa

1

Hungary

4. List of Minolira drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103517 EPI HLTH Pharmaceutical compositions for minocycline
Apr, 2036

(12 years from now)

Do you want to check out MINOLIRA patents from before 2022?

Market Authorisation Date: 08 May, 2017

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

MINOLIRA family patents

2

United States

1

India

IB

1

IB

5. List of Solodyn drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8252776 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US8722650 BAUSCH Extended-release minocycline dosage forms
Jun, 2025

(2 years from now)

US8268804 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US7790705 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US7919483 BAUSCH Method for the treatment of acne
Mar, 2027

(3 years from now)

US7541347 BAUSCH Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(3 years from now)

US7544373 BAUSCH Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(3 years from now)

US9192615 BAUSCH Method for the treatment of acne and certain dosage forms thereof
Nov, 2031

(8 years from now)

Do you want to check out SOLODYN patents from before 2022?

Market Authorisation Date: 08 May, 2006

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of SOLODYN before it's patent expiration?
More Information on Dosage

SOLODYN family patents

23

United States

2

Japan

1

Canada

1

China

1

South Africa

1

Australia

1

New Zealand

1

Norway

1

European Union

6. List of Ximino drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7790705 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US8252776 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US8268804 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US7919483 JOURNEY Method for the treatment of acne
Mar, 2027

(3 years from now)

US7544373 JOURNEY Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(3 years from now)

US7541347 JOURNEY Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(3 years from now)

Do you want to check out XIMINO patents from before 2022?

Market Authorisation Date: 11 July, 2012

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

XIMINO family patents

23

United States

2

Japan

1

Canada

1

China

1

South Africa

1

Australia

1

New Zealand

1

Norway

1

European Union

7. List of Zilxi drug patents

Can you believe ZILXI received compensation for the extended wait time during the regulatory approval process?
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10946101 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(7 years from now)

US10213512 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10322186 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

Do you want to check out ZILXI patents from before 2022?

Market Authorisation Date: 28 May, 2020

Treatment: Treatment of inflammatory lesions of rosacea.

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of ZILXI before it's patent expiration?
More Information on Dosage

ZILXI family patents

52

United States

5

Canada

IB

5

IB

2

Australia

2

Israel

1

Mexico

1

Brazil

1

China

1

South Africa

1

United Kingdom

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic